Opella reaches study milestone for CialisParis, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tadalafil 20-milligram side effects are often ... under the brand name Adcirca®. And it’s sometimes prescribed for pulmonary arterial hypertension (PAH), a form of high blood pressure affecting ...
The phase III A DUE trial showed significantly greater pulmonary vascular resistance improvements with the fixed-dose combination over macitentan (Opsumit) or tadalafil (Adcirca) monotherapy.
The company produces pharmaceutical products such as prostacyclin analogs (Remodulin, Tyvaso, Orenitram) for PAH and PH-ILD, Adcirca (tadalafil) for PAH, and Unituxin (dinutuximab) for high-risk ...
The company produces pharmaceutical products such as prostacyclin analogs (Remodulin, Tyvaso, Orenitram) for PAH and PH-ILD, Adcirca (tadalafil) for PAH, and Unituxin (dinutuximab) for high-risk ...